Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Alzheimers Dis ; 9(2): 195-205, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16873966

RESUMO

Synapse loss and neuronal death are key features of Alzheimer's disease pathology. Disrupted axonal transport of mitochondria is a potential mechanism that could contribute to both. As the major producer of ATP in the cell, transport of mitochondria to the synapse is required for synapse maintenance. However, mitochondria also play an important role in the regulation of apoptosis. Investigation of aluminum (Al) maltolate induced apoptosis in human NT2 cells led us to explore the relationship between apoptosis related changes and the disruption of mitochondrial transport. Similar to that observed with tau over expression, NT2 cells exhibit peri-nuclear clustering of mitochondria following treatment with Al maltolate. Neuritic processes largely lacked mitochondria, except in axonal swellings. Similar, but more rapid results were observed following staurosporine administration, indicating that the clustering effect was not specific to Al maltolate. Organelle clustering and transport disruption preceded apoptosis. Incubation with the caspase inhibitor zVAD-FMK effectively blocked apoptosis, however failed to prevent organelle clustering. Thus, transport disruption is associated with the initiation, but not necessarily the completion of apoptosis. These results, together with observed transport defects and apoptosis related changes in Alzheimer disease brain suggest that mitochondrial transport disruption may play a significant role in synapse loss and thus the pathogenesis or Alzheimer's disease.


Assuntos
Apoptose/efeitos dos fármacos , Núcleo Celular/efeitos dos fármacos , Núcleo Celular/ultraestrutura , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/ultraestrutura , Compostos Organometálicos/toxicidade , Pironas/toxicidade , Doença de Alzheimer/patologia , Clorometilcetonas de Aminoácidos/toxicidade , Animais , Antineoplásicos/toxicidade , Linhagem Celular , Citocromos c/metabolismo , Inibidores Enzimáticos/toxicidade , Humanos , Peróxido de Hidrogênio/toxicidade , Imuno-Histoquímica , Marcação In Situ das Extremidades Cortadas , Microtúbulos/efeitos dos fármacos , Neuritos/ultraestrutura , Fármacos Neuroprotetores/toxicidade , Nocodazol/toxicidade , Organelas/efeitos dos fármacos , Organelas/ultraestrutura , Coelhos , Estaurosporina/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA